However, over the years evidence has shown that CD164 can promote tumorigenesis, invasion, and metastasis in lymphoma [25, 26], prostate cancer [13], colon cancer [12], ovary cancer [16], lung cancer [11, 15] and brain cancer [14, 21]. The gene discussed is CD164; the disease is prostate carcinoma.